Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year book value per share growth
Latest
54.25%
↑ 1141% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
4.37%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 54.25% |
| Q3 2025 | 123.93% |
| Q2 2025 | -0.89% |
| Q1 2025 | -47.74% |
| Q4 2024 | 281.56% |
| Q3 2024 | -300.33% |
| Q2 2024 | -79.65% |
| Q1 2024 | -63.43% |
| Q4 2023 | -28.38% |
| Q3 2023 | 139.22% |
| Q2 2023 | -44.76% |
| Q1 2023 | 315.75% |
| Q4 2022 | -57.56% |
| Q3 2022 | -36.15% |
| Q2 2022 | -25.31% |
| Q1 2022 | -32.76% |
| Q4 2021 | -3.64% |
| Q3 2021 | -7.25% |
| Q2 2021 | -14.89% |
| Q1 2021 | 56.44% |
| Q4 2020 | -30.38% |
| Q3 2020 | -16.86% |
| Q2 2020 | 35.98% |
| Q1 2020 | 2.06% |
| Q4 2019 | -10.44% |
| Q3 2019 | -13.27% |
| Q2 2019 | -4.33% |
| Q1 2019 | -10.74% |
| Q4 2018 | -1.31% |
| Q3 2018 | 9.00% |
| Q2 2018 | -4.80% |
| Q1 2018 | 1.31% |
| Q4 2017 | -5.38% |
| Q3 2017 | 3.97% |
| Q2 2017 | -4.20% |
| Q1 2017 | -2.22% |
| Q4 2016 | -2.74% |
| Q3 2016 | -4.16% |
| Q2 2016 | -0.72% |
| Q1 2016 | 5.66% |